ROCK HILL, S.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced that Andrew Johnson, the company’s executive vice president, chief legal officer, is taking on expanded responsibilities as chief corporate development officer. In this role, he will not only lead the company’s mergers and acquisitions but will also lead the establishment of new strategic partnerships in support of the company’s expanding business needs. Mr. Johnson has been with 3D Systems for more than 16 years, and during this time has led over 60 M&A transactions for the company, and has played a key role in the development of several strategic partnerships. His strategic vision, experience, and knowledge of the additive manufacturing industry make him well suited to take on this expanded responsibility as chief corporate development officer, in addition to his current role as chief legal officer. Mr. Johnson holds a BA from Miami University, an MBA from the Ross School of Business at the University of Michigan, and a JD from the University of Virginia.
“Our core strength as a company, one that differentiates us from our competitors, is our relentless application focus in meeting our customers' most important challenges,” said Dr. Jeffrey Graves, president and CEO, 3D Systems. “To be effective in this approach, it is essential for us to be the leader in bringing to bear a broad range of core printing technologies, from metals to polymers and biologics, in combination with market-leading materials and software solutions. To do this on an ever-larger scale, we must increasingly seek strategic partnerships, ranging from basic technology to commercial channels to market. This activity is essential in order to capitalize on the full spectrum of exciting opportunities that are opening ahead of us, as additive manufacturing enters full-scale production environments. Andy’s experience and knowledge of our company and the industry broadly position him very well for success in this expanded role.”
Mr. Johnson’s responsibilities will span the entire range of the company’s interests. One of the key emerging areas that he will be addressing is the increasing partnership opportunities 3D Systems now has in regenerative medicine. With the technical progress achieved by 3D Systems’ regenerative medicine team, under the leadership of Chuck Hull, chief technology officer for regenerative medicine, and in partnership with United Therapeutics, along with the acquisitions of Allevi and Volumetric Biotechnologies, the company possesses unique capabilities that are needed to pursue an increasing number of new biologic applications. To capitalize on this potential, Mr. Johnson will explore application partnerships that could accelerate the company’s growth in these new and exciting markets.
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.
About 3D Systems
More than 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at www.3dsystems.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b20070fd-a0ac-4f23-93a9-4aba4540cad5